Cambridge Cognition partly-owned spin-off gets GBP1.5 million funding
(Alliance News) - Cambridge Cognition Holdings PLC on Tuesday said that a precision neuroscience company that it spun-out from and partly owns has accessed GBP1.5 million in funding for clinical development of a schizophrenia drug. Read More